Jane M. Blazeby
Economics and Econometrics · 2006–2021
A researcher in the Science corpus: 10 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Economics and Econometrics — 34 citations into it
- Statistics and Probability — 33 citations into it
- Sociology and Political Science — 27 citations into it
Whom Jane M. Blazeby trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Jane M. Blazeby's perspective
Ordered by how strongly the researchers Jane M. Blazeby trusts endorse each paper. Same corpus, a different order for every researcher.
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
- Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
- Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? (PLoS Medicine)
- GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
- The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews (British medical journal)
- Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. (Journal of Clinical Epidemiology)
- The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (Quality of Life Research)
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendations (Pain)
- Research: increasing value, reducing waste 1 How to increase value and reduce waste when research priorities are set
Their papers
- Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. (2013) — 1,218 citations
- Developing core outcome sets for clinical trials: issues to consider (2012) — 1,488 citations
- The COMET Handbook: version 1.0 (2017) — 1,669 citations
- A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance (2021) — 4,809 citations
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) — 1,649 citations
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension (2018) — 679 citations
- Core Outcome Set-STAndards for Development: The COS-STAD recommendations (2017) — 626 citations
- No surgical innovation without evaluation: the IDEAL recommendations. (2009) — 1,710 citations
- Challenges in evaluating surgical innovation (2009) — 612 citations
- The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. (2006) — 624 citations